Skip to main content

Table 1 Relationship between METTL16 expression and clinicopathologic features of HCC patients

From: METTL16/IGF2BP2 axis enhances malignant progression and DDP resistance through up-regulating COL4A1 by mediating the m6A methylation modification of LAMA4 in hepatocellular carcinoma

 

Characteristics

n = 62

METTL16 expression

P value

Low(n = 31)

High(n = 31)

Age (years)

   

0.7972

≤ 50

26

14

12

 

> 50

36

17

19

 

TNM grade

   

0.0003*

I+II

27

21

6

 

III

35

10

25

 

Lymph node metastasis

   

0.0008*

Positive

32

9

23

 

Negative

30

22

8

 
  1. TNM, tumor-node-metas-tasis; *P < 0.05